In addition, the results of Fig. S6 suggest that Rras2(Q72L)fl/fl xmb1-Cre mice expressing a constitutively active “oncogenic” mutant of R-Rras2 do not develop CLL because they do not activate those BCR signaling pathways. The gene discussed is RRAS2; the disease is B-cell chronic lymphocytic leukemia.